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Objective: Carotid arteriography (CA) is an important method of assessing carotid artery occlusive disease and is the best
method of planning for carotid angioplasty and stent placement (CAS). This study compared the results of CA performed
by vascular surgeons in a contemporary series against widely recognized interdisciplinary quality standards for this
procedure. Although many vascular surgeons perform CA, there is a paucity of data about its safety, efficacy, and
compliance with quality standards in vascular practice. The importance of quality CA will likely increase as CAS emerges
to assume a broader clinical role.
Method: Carotid arteriograms performed by seven vascular surgeons at three institutions from September 2000 to May
2004 were reviewed. These results were compared with quality standards for the performance of CA.
Results: Five hundred three carotid arteriograms were performed over 45 months. Indications for the procedure were
extracranial cerebrovascular disease (86%), trauma (5%), and other conditions (9%). Indications for the procedure were
appropriate in 100% of patients (as determined by guidelines document) and exceeded the recommended standard of
appropriate indications in 99%. All procedures successfully provided the information required, exceeding the threshold of
98% for procedural success. Reversible neurologic deficits occurred in 0.6% (two transient ischemic attacks and one
stroke) compared with the threshold of 2.5%. A permanent neurologic deficit occurred in 0.2% (1 patient) compared with
the published guideline of 1% after carotid arteriography. Major non-neurologic complications occurred in 1.2% (6
patients), less than the standard of 2.0%.
Conclusions: The safety and efficacy of a contemporary series of CA performed in vascular surgery practice compared
favorably with recognized interdisciplinary quality standards for this procedure. Ensuring safe and effective CA is likely
to support the successful growth of CAS as a treatment option. (J Vasc Surg 2005;41:238-45.)Vascular surgeons in most communities are clinically
responsible for the management of patients with extracra-
nial carotid occlusive disease. As the providers of care for
these patients, vascular surgeons have a unique interest in
the safety and success of all carotid procedures, including
carotid arteriography (CA). The development of carotid
angioplasty and stent placement (CAS) has prompted a
re-evaluation of CA, its evolving role in vascular practice, its
contemporary results, and its future.
CA remains an essential tool in assessing patients both
before and after mechanical treatment for carotid stenosis.
It is especially useful prior to carotid endarterectomy in
patients in whom noninvasive studies alone are not ade-
quate, when planning CAS, for guidance during the CAS
procedure, and for completion studies after either carotid
endarterectomy or CAS. Many of the techniques required
for safe and successful CA are also required for CAS. This
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238study assessed the safety and efficacy of CA performed by
vascular surgeons and compared the practice with pub-
lished guidelines for the quality performance of this
procedure.1
The risk/benefit ratio associated with CA appears to be
changing as carotid stenting is introduced. CA in modern
practice is not often required to determine the degree of
carotid artery stenosis; sophisticated and less invasive stud-
ies are usually able to fulfill this task.2,3 Instead, CA is being
used to plan and guide CAS and has become a pathway to
treatment, reflecting a potential increase in the benefit that
patients may derive from CA.
In addition, the current risk of CAmay not be as high as
was reported in the past. Much of our understanding of the
risk of CA is based upon data collected more than a decade
ago during carotid surgery trials such as the Asymptomatic
Carotid Atherosclerosis Study (ACAS).4 Although CA has
not been studied extensively over the past decade, substan-
tial technical improvements have occurred in this proce-
dure, including the routine use of high-resolution digital
imaging, hydrophilic guidewires, smaller caliber and less
traumatic catheters, complementary data collection with
magnetic resonance angiography and duplex scanning, and
improved endovascular skills. Current techniques may be
associated with less neurologic risk, thus further improving
the utility of CA.
Although a substantial number of vascular surgeons are
currently performing CA, there is little information about
the performance of CA by vascular surgeons and its results
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incorporate CAS into their respective practices, it is an
essential step to ensure that the technique, indications,
results, and risks of CA are acceptable, because this proce-
dure serves as a pathway to future care.
METHODS
Consecutive carotid arteriograms (503 procedures in
485 patients) performed by seven vascular surgeons at three
institutions from September 2000 to May 2004 were re-
viewed. These three institutions (two academic, one pri-
vate) have endovascular fellowships and carotid stent pro-
grams staffed by vascular surgeons. Vascular registries were
queried for CA cases, and data for these cases were retro-
spectively collected and entered into a computer database.
Data collected included patient demographics, indications
for the procedure, neurologic status, technical aspects of
the procedure, results of the study, and complications.
Patient characteristics are presented in Table I.
Technique of CA. CA was performed using previ-
ously described techniques and algorithms.5 Patients pro-
vided informed consent prior to CA after a discussion of the
benefits and risks with the attending surgeon who per-
formed the procedure. Most patients with extracranial ce-
rebrovascular disease underwent evaluation of the carotid
arteries with duplex ultrasonography scanning prior to
Table I. Demographic and clinical characteristics of
patients undergoing carotid arteriography
Characteristics
Percentage
(N  485)
Age (mean) 64  19 years
Gender (male/female) 62%/38%
History
Coronary artery disease 55%
Hypertension 65%
Diabetes 36%
Hyperlipidemia 36%
Smoking 45%
Stroke history 26%
Indication for carotid arteriogram
Define carotid occlusive disease 86%
Define etiology of hemorrhage 3%
Define anatomy of intracranial aneurysms
and AVMs
2%
Evaluate vasospasm 1%
Define presence of extent of trauma 5%
Define vascular supply to tumors 2%
Define presence of vasculitis 1%
Diagnose and/or define congenital or
anatomic anomaly
1%
Define presence of venous occlusive disease 1%
Symptoms prior to carotid arteriogram
(among patients with cerebrovascular
disease)
Asymptomatic 34%
TIA 35%
Stroke 24%
Vertebrobasilar or nonspecific 7%
AVM  Arteriovenous malformation; TIA  transient ischemic attack.arteriography. In most instances, CA was performed using fixed im-
aging equipment in the endovascular operating room, an-
giographic suite, or cardiac catheterization laboratory. CA
was occasionally performed in a standard operating room
with a portable C-arm (OEC 9800, Salt Lake City, Utah).
Procedures were performed with monitoring by anesthesia
personnel and light intravenous sedation. Access was usu-
ally performed via the femoral artery and occasionally via
the brachial artery through a 4F or 5F sheath. Heparin was
administered at the discretion of the attending surgeon.
Some conditions, such as trauma and intracranial hemor-
rhage, precluded the use of systemic heparin.
Most procedures included an arch aortogram and se-
lective unilateral or bilateral carotid catheterization and
carotid and cerebral arteriography. Many patients also re-
quired arteriography and either subclavian (unilateral or
bilateral) or vertebral catheterization, or both, followed by
posterior circulation asteriography.
Nonionic contrast was routinely used. Gadolinium was
used to supplement standard contrast for selective arteriog-
raphy in patients with severe renal insufficiency.
A pigtail catheter was used to perform arch aortogra-
phy. Selective catheterization was usually performed with
simple curve catheters (H1 headhunter, angled taper Glide-
cath [Boston Scientific], or vertebral). Complex curve cath-
eters, such as Simmons, were used at the discretion of the
attending, usually for unfavorable arch configurations such
as bovine arch or segment III vessel.6 Selective catheteriza-
tions within this vascular family were described as first-
order (innominate, left common carotid artery, left subcla-
vian artery), second-order (right common carotid artery,
right subclavian artery, left vertebral artery), or third-order
(right vertebral artery).
The procedures usually comprised arch aortography,
unilateral or bilateral carotid and cerebral arteriography,
and selective posterior circulation arteriography. Arch aor-
tography only, without selective carotid catheterization,
was performed in 2% of the patients whose arch disease
precluded safe carotid catheterization. Selective carotid
catheterization was performed in 98%; most underwent
bilateral common carotid catheterization. Unilateral ca-
rotid catheterization was performed in some patients to
limit contrast load in patients with renal insufficiency, in
patients with a known normal contralateral carotid, and in
patients who underwent CA to assess the effect of therapy
on one side. Occasionally it was precluded by the presence
of arch or proximal arch branch disease.
When carotid catheterization was performed, cerebral
arteriograms were routinely obtained. Standard views in-
cluded an anterior-posterior with slight craniocaudal angu-
lation and a 90-degree lateral. When intracranial vascular
variants or abnormalities were visualized, further evaluation
was performed using a previously described algorithm.7
The access sheath was usually left in place at the completion
of the procedure unless a closure device was placed. Pa-
tients were transferred to a recovery area where the sheath
was removed after the activated clotting time was at an
acceptable level and manual pressure held. Carotid arterio-
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this study.
Specific factors associated with the procedure were
tabulated, including type and location of arterial access,
heparin administration, areas evaluated by arteriography,
catheters used, and location where the procedure was per-
formed.
Among patients with carotid stenosis, indications for
CA evolved during the study period concomitant with the
increasing usage of CAS. At the conclusion of the study
period in May 2004, all patients considered for carotid
endarterectomy or carotid stenting and without significant
contraindications to CA underwent CA prior to treatment.
Comparison with quality improvement guidelines.
These results were compared with quality standards for the
performance of carotid arteriography from the cooperative
study of the American Society of Interventional and Ther-
apeutic Neuroradiology, American Society of Neuroradiol-
ogy, and the Society of Cardiovascular and Interventional
Radiology.1 Published performance thresholds that should
be met or exceeded by physicians performing CA included
appropriateness of the indications for CA (99%), success
rate (98%), and neurologic and non-neurologic complica-
tions of the procedure. Reversible neurologic deficit, in-
cluding transient ischemic attack (TIA) and reversible
stroke, should not exceed 2.5%. Permanent neurologic
deficit should not exceed 1.0%. Thresholds for major non-
neurologic complications include renal failure (0.2%), ac-
cess site arterial occlusion (0.2%), pseudoaneurysm or arte-
riovenous fistula (0.2%), and hematoma requiring
transfusion or evacuation (0.5%). All major complications
should not exceed 2.0%.
Appropriate indications for adult diagnostic neuroan-
giography should be present in 99% ormore of the patients.
These include
1. Define presence or extent of vascular occlusive disease
and thromboembolic phenomena,
2. Define etiology of hemorrhage (subarachnoid, intraven-
Table II. Neurologic complications in large series (200
Author Year Arteriograms All events
Earnest8* 1983 1517 2.6% 
Thomson9 1986 314 NA 
McIvor10 1987 230 11.3% 
Dion11 1987 1002 NA 
Hankey12 1990 382 2.6% 
Warnock13 1993 395 3.9% 
Davies14* 1993 200 10% 
Heiserman15 1994 1000 NA
ACAS4 1995 414 NA
Bain16 1998 272 NA
Johnston17 2001 569 0.9%
Present study 2004 503 0.8%
TIA  Transient ischemic attack; ACAS  Asymptomatic Carotid Atheros
*Included one death.tricular, parenchymal, and craniofacial),3. Define presence, location, anatomy of intracranial aneu-
rysms and vascular malformations,
4. Evaluate vasospasm related to subarachnoid hemor-
rhage,
5. Define presence of extent of trauma to cervicocerebral
vessels (eg, dissection, pseudoaneurysm),
6. Define vascular supply to tumors,
7. Define presence or extent of vasculitis (infectious, in-
flammatory, or drug-induced),
8. Diagnose and/or define congenital or anatomic anom-
aly (eg, vein of Galen fistula),
9. Define presence of venous occlusive disease (eg, dural,
sinus, cortical, and deep),
10. Outline vascular anatomy for planning and determin-
ing the effect of therapeutic measures, and
11. Perform physiologic testing of brain function (eg,
Wada test).1
A successful carotid arteriogram provides a sufficient
technical evaluation to establish or exclude the presence of
vascular pathology. Procedural success should be achieved
in 98% or more of the patients undergoing CA.
Neurologic complications that occur within 72 hours
of the procedure are attributed to the carotid arterio-
gram and are defined by the duration and severity of the
deficit. A neurologic deficit that resolves within 24 hours
of its occurrence is considered a TIA, and a deficit lasting
more than 24 hours is a stroke. A deficit that resolves
within 7 days is defined as a reversible stroke, and a
neurologic deficit that lasts more than 7 days is consid-
ered a permanent stroke.
Major complications are defined as those events that
require additional therapy, an unplanned increase in the
level of care, prolong the hospitalization more than a day,
or cause permanent adverse sequelae. Results of the carotid
arteriograms performed in this series were compared di-
rectly with recommended thresholds for quality perfor-
nts) of carotid arteriography since 1980
Neurologic complications
TIA Stroke Reversible Permanent
2.2% 0.4% 0.1% 0.3%
NA 1.5% 0.9% 0.6%
NA NA NA 4.8%
NA 3.1% NA 0.4%
0.5% 2.1% 0.8% 1.3%
2.6% 1.3% 0.8% 0.5%
5.0% 5.0% 1.0% 4.0%
NA 1.0% 0.5% 0.5%
NA 1.2% NA NA
NA 1.0% NA NA
0.4% 0.5% 0.3% 0.2%
0.4% 0.4% 0.2% 0.2%
is Study; NA  not applicable.patie
clerosmance of this procedure.
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During the 45-month study period, 503 carotid arte-
riograms were performed in 485 patients. Among these,
86% (n 431) were performed for the evaluation of carotid
artery occlusive disease. Other indications for CA were
trauma (5%) and miscellaneous lesions (9%) (Table I).
Procedures were performed in the angiographic suite in
46%, an endovascular operating room in 20%, the operating
room with a portable C-arm in 18%, and the cardiac cath-
eterization laboratory in 16%.
CA was performed using a sheath in 100% of cases. A
5F sheath was used in 84%, and 4F or 6F sheaths were used
in 16%. Access was femoral in 96% and brachial in 4%.
Heparin was administered in 75% of patients. Themean
heparin dose administered was 3580  1140 units.
Selective carotid catheterization was performed in
98% of cases; 10 patients underwent arch aortogram
only. Bilateral carotid catheterizations were performed
in 374 patients, and unilateral carotid catheterization
was performed in 119. A total of 867 common carotid
artery catheterizations and 444 subclavian artery cath-
eterizations were performed. In the course of this study,
655 first-order, 772 second-order, and 118 third-order
selective catheterizations were performed. Complex
curve cerebral catheters were used in 14% of patients, and
all other catheterizations were achieved with simple
curve catheters. More than one cerebral catheter was
required in 8% of patients.
Among the 431 patients whose indication for CA was
carotid artery disease, significant disease was identified at
the aortic arch in 17 patients (3.9%). In 29 patients (6.7%),
incidentally identified intracranial vascular pathology was
present in the form of aneurysm in 7 patients (1.6%) and
significant cerebral artery occlusive disease in 22 patients
(5.1%). None of these lesions required intervention during
the study period.
Neurologic complications of CA occurred in four pa-
tients (0.8%) consisting of two TIAs (0.4%), one reversible
stroke (0.2%), and one permanent stroke (0.2%). From the
criteria set forth in the guidelines, the rate of reversible
neurologic deficit was 0.6%, and the rate of permanent
neurologic deficit was 0.2%. The four patients who had
neurologic deficits were:
● A 67-year-old woman with a symptomatic 80% left ca-
rotid stenosis and subclavian steal syndrome underwent
arch aortogram, carotid, vertebral, and cerebral arterio-
gram. A posterior circulation stroke developed after the
vertebral artery injection. Her length of stay was 6 days.
At 1 week, she still had difficulty with balance. This was
the only permanent deficit in the series. She was later
treated with left carotid endarterectomy and left carotid-
subclavian bypass.
● An 84-year-old woman with TIAs due to 95% right
carotid stenosis. Several hours after arteriogram, a left
hemiparesis developed She underwent cerebral artery
thrombolysis with tissue-plasminogen activator and wastreated with a right carotid stent. Her deficit was resolved
at 1 week.
● A 65-year-old man with altered mental and intracranial
hemorrhage. No aneurysm was found during arteriogra-
phy. The following day, he had an episode of left upper
extremity weakness that resolved within hours.
● A 65-year-old woman with multiple TIAs due to an 80%
left carotid stenosis. She experienced a TIA as the sheath
was removed. This resolved within a few minutes.
Major non-neurologic complications occurred in six
patients (1.2%). These included one femoral puncture site
occlusion that required surgery, two large groin hemato-
mas, one retroperitoneal hematoma, one brachial hema-
toma, and one pseudoaneurysm. Thirty days after carotid
arteriography, one patient had a mild but persistent neuro-
logic deficit.
The present series was compared with published
thresholds.1 Appropriate indications for the procedure
were present in 100% of patients compared with the rec-
ommended threshold of 99%. The success rate of the
procedure was 100%, exceeding the recommended stan-
dard of 98%. Reversible neurologic deficits occurred in
0.6% compared with an accepted threshold of 2.5%. A
permanent neurologic deficit occurred in 0.2% versus a
1.0% threshold. Major non-neurological complications oc-
curred in 1.2%, below an acceptable level of 2.0%. All seven
surgeons performed CA within recommended standards
for the procedure.
Among the 431 patients who underwent CA for ca-
rotid artery occlusive disease, 230 underwent carotid stent
placement and 178 underwent carotid endarterectomy. In
23 patients, treatment was either not indicated in light of
arteriographic findings or the patient decided against rec-
ommended treatment.
DISCUSSION
The goal of this study was to assess the safety and
efficacy of CA performed by vascular surgeons and to
compare these results with published guidelines.1 This is
the first comprehensive study of CA in contemporary vas-
cular surgery practice. The results of CA performed by
vascular surgeons in the present study were acceptable and
compared favorably to published guidelines for appropri-
ateness, success, and safety. This study shows that routine
vascular practice can include safe and successful CA. These
data also suggest that the risks of CA are lower now than
they were in the ACAS era when the current paradigm of
duplex scanning alone prior to carotid endarterectomy was
developed. The benefits of CA have also increased as it is
the best study to plan CAS.
As the providers of care for patients with carotid occlu-
sive disease, vascular surgeons have developed substantial
concerns over a period of many years about the stroke risk
of CA. The rate of neurologic complications in large studies
of CA during the era preceding the ACAS trial ranged from
2.6% to as high as 11.3% (Table II). These studies com-
prised more than 5000 patients. The stroke rate in two
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tion of patients was 2.1% and 3.1%, respectively.11,12
The most often cited stroke risk for CA in the present
era was produced during the ACAS trial.4 Among the 414
patients undergoing carotid arteriography in ACAS, 5 pa-
tients (1.2%) had strokes. The stroke risk for CA rivaled that
attributed to the endarterectomy itself (1.5%).
During the same time frame, carotid duplex scanning
reached a level of reliability and sophistication that permit-
ted the performance of carotid endarterectomy on the basis
of noninvasive studies alone in many patients.2,3 Because
CA was not usually required to determine the degree of
stenosis and it appeared to pose a significant stroke risk,
most vascular practices have been using it only very selec-
tively over the past 10 years.18
Patients were randomized in the ACAS trial between
1988 and 1993. An extensive, multiview, four-vessel ca-
rotid arteriogram was required for patients randomized to
endarterectomy to precisely determine the degree of steno-
sis and to identify any intracranial pathology that would
preclude surgery. The extensiveness of the CA required and
the use of cut film for many cases committed patients to
longer catheter times and larger contrast loads, which have
been associated with an increased risk of stroke.10,11
During the decade that followed the ACAS study,
many technical developments have contributed to make
CA simpler and safer. Digital subtraction technology is the
routine for arteriography in most centers, including those
participating in this study. This permits a faster, more
detailed study with less contrast administration. The mech-
anism of stroke associated with CA is often vessel injury or
lesion disruption from catheter manipulation. Hydrophilic
coating of guidewires and catheters, smaller caliber cathe-
ters, and high-resolution imaging have contributed to
greater technical ease in maneuvering cerebral catheters.
The use of magnetic resonance angiography or carotid
duplex scanning prior to CA assists the angiographer in
directing the study to the important areas of interest. Less
toxic contrast agents have facilitated the ease of performing
CA and decreased systemic complications.
Very few studies of CA have been published in the
decade since the ACAS trial was completed.16,17 The larg-
est and most recent of these included over 500 patients
reviewed by neurologists, and the stroke rate was 0.5%.17
Some of the significant factors that have correlated
strongly with stroke after CA in previous studies are no
longer at issue. These included performance by trainees,
use of ionic contrast, high-volume contrast administration,
larger cerebral catheters (eg, 6F), and multiple catheter
exchanges.8,10,11,14,15
● Although each of the institutions in this study was a
training site, all procedures were performed with the
attending vascular surgeon scrubbed and participating in
the procedure.
● Only nonionic contrast was used, a significant change
frommany earlier studies in which ionic contrast use was
routine.8-13● Contrast load was usually limited by using two tech-
niques: (1) directing examinations with noninvasive
studies and focusing the carotid arteriogram on the
specific areas of interest, and (2) the use of half-strength
contrast, which often provides adequate images when
using high-resolution digital equipment. Although we
did not tabulate contrast administration data for all cases,
the mean for the recorded cases in this study was 62 18
mL. This is substantially less than the amount of contrast
administered in previously published studies (mean 93 to
139 mL).10,11,15
● The variety, special features, and availability of cerebral
catheters make multiple catheter exchanges or use of a
larger catheter uncommon. Multiple cerebral catheter
exchanges were required in 32% of studies performed by
Dion et al11 and in 34% by Earnest et al8 compared with
8% of patients who required a catheter exchange in the
present study. All procedures in this study were per-
formed with 4F or 5F cerebral catheters, whereas larger
catheters were required in up to 34% of the patients in
earlier studies and this correlated with the risk of stroke.8
Unfortunately, other factors that have been associated
with stroke after CA, such as advanced age, diabetes melli-
tus, hypertension, and symptomatic carotid stenoses, are
likely to be present in patients undergoing CA.8,10-12,14,15
Therefore, further modification of patient selection to de-
crease the neurologic complications of CA based on these
demographics may not be possible.
Although this study did not include independent eval-
uation by a neurologist, the only patients who had an added
length of stay due to neurologic complications from CA
were three of the four patients who experienced TIA or
stroke. The risk of stroke from CA in this study was 0.4%.
Neurologists conducted the largest study of CA (569 pa-
tients) since ACAS and demonstrated a stroke rate of 0.5%
after CA, very similar to that found in the present study.17
These data suggest that the current neurologic risk of CA is
less than it was when it was evaluated in the past.
CA is presently being performed by specialists from
multiple disciplines, including interventional neuroradiol-
ogy, interventional radiology, neuroradiology, general ra-
diology, cardiology, vascular medicine, neurosurgery, and
vascular surgery.1,19,20 Regardless of which specialist per-
forms CA, the results should demonstrate that the proce-
dure conforms to a high standard of quality. Specific skills
required for CA that are transferable to CAS include arch
assessment, carotid catheterization, cerebral angiography,
and carotid access.
From our combined experience of directing the train-
ing of more than 40 endovascular surgery fellows, we
believe that somewhere between 20 and 40 carotid arterio-
grams are required to gain skill with this procedure. We
believe that excellent results can be achieved by vascular
surgeons who possess endovascular skills and knowledge of
carotid disease, have studied basic CA techniques, and have
performed a number of procedures. Future guidelines for
performing CAS are likely to include CA as a prerequisite,
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arteriograms as a minimum requirement.21
The finer detail of arch, carotid bifurcation, and intra-
cerebral arterial anatomy that is provided by CA is not
required for all patients undergoing carotid endarterec-
tomy but is of significant value in planning and performing
CAS. CA is no longer simply a diagnostic study; it has
become a pathway to future care for patients who will be
treated with CAS. The benefit of CA for selected patients
may be higher now because of the added option of CAS.
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DrDouglas Hood (Los Angeles, Calif). I would like to thank
the program committee for allowing me to open this discussion
today. Dr Schneider and colleagues present a series of over 500
carotid arteriograms with a high degree of technical success and a
low incidence of adverse events falling within the parameters of
quality assurance guidelines previously published by a multidisci-
plinary group. These results are not unexpected, given that the
operators are a very experienced and accomplished group of endo-
vascular interventionalists. But, importantly, these are the results
that any of us wishing to perform these procedures must achieve if
we are to be competitive with other specialists in this arena. I have
some technical questions for the authors.
Counting the number of selective catheterizations that are
included with the manuscript, it appears that not all patients
underwent bilateral studies. What were the criteria for bilateral
versus unilateral arteriograms?
Intracranial pathology was also demonstrated in a significant
number of these patients, approximately 1.5% to 2% included in
the manuscript. What is your algorithm for evaluating the cerebral
vessels? Should it be done routinely or selectively? And did the
authors perform simple AP and lateral views of the cerebral circu-Four neurologic deficits occurred in this series, one of which
was permanent; and again, these are extremely good results com-
pared with historic controls. But, Dr Schneider, can you identify
any technical or anatomic reasons to explain these events, and can
you offer us any pearls to assist us in avoiding a similar fate in our
patients?
As you note in the manuscript, the use of carotid angiography
was drastically reduced in the last decade, as the accuracy and
reliability of noninvasive testing made angiography unnecessary.
This was an accomplishment largely driven by vascular surgeons,
notably many members of this organization, and we took great
pride in making the diagnosis and management of carotid disease
safer for our patients by eliminating the need for this invasive
procedure. I don’t imagine that any sort of formal correlation with
noninvasive studies was made in conjunction with this report, but
I suspect that many, if not most, of these diagnostic studies were
actually strategic in nature, performed to confirm the findings of a
noninvasive test in order to assess the possibility of or to guide a
carotid stenting procedure. Were any stent placements included in
this report, or was stenting performed by the authors at a subse-
quent procedure? Dr Schneider, that is really a softball way of
saying, did you really need to do all these carotid angiograms?
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and for documenting that surgeons are indeed able to safely and
effectively complete these diagnostic endovascular procedures in
the cervical and cerebral circulations. Thank you.
Dr Peter Schneider. Carotid arteriography is really a moving
target. For us surgeons, we have a gut-wrenching moral dilemma
about having anybody get a carotid arteriogram. However, we are
the only ones who feel that way and we are in self-imposed exile. All
the other specialists who intend to treat carotid disease, and there
are lots now, don’t have that same dilemma.
We did perform selective bilateral catheterization in 374 of the
patients, and in 119 patients we only did unilateral. The main
reasons for performing unilateral catheterization were a need to
limit contrast, when the contralateral side was a known normal,
when assessing the results of treatment, and when it was some type
of follow-up study.
The amount that we learn from cerebral arteriography is
tremendous. The cost of giving up cerebral arteriography was a loss
of pattern recognition. When we look at tibial and pedal arteries,
we see and understand things that many other specialists do not
see. We used to have that facility with cerebral arteries, but we lost
it because we quit doing carotid arteriography. I had to go get a
book and study it and, by the way, it looks the same as it did when
I studied it 20-plus years ago. When you get that pattern recogni-
tion back, it really feels good, and you become of greater value to
your patients.
We perform a standard AP (with a little craniocaudal so that
you can get the transverse portion of the middle cerebral off of the
petrous bone) and a lateral of the head. We evaluate the arteries for
signs of aneurysm, stenosis, collaterals, congenital anomalies, and
other lesions. If there is a hint of any significant disease, we perform
views with various degrees of craniocaudal angulation or side-to-
side rotation, depending upon which artery appears to be involved.
Common denominators among the strokes that occurred
were hard to identify. The one stroke that left a permanent deficit
was from a vertebral artery injection. I have a lot of concern about
vertebral injections. If you are doing vertebral injections, consider
hand injecting first. If it happens to be a vertebral that only runs off
into a pica, you might fill the whole thing with a few milliliters of
contrast, so an injection with significant pressure and volume
would not be warranted. Vertebral arteries are prone to spasm. I
would caution all to be very clear about who needs a vertebral
injection and who does not and to be very careful when you do it.
About 80% of the carotid stenosis patients undergoing arte-
riography in this study went on to therapy within a month, either
endarterectomy or stent.
We didn’t do any specific correlation with the results of
noninvasive studies, but nearly every patient that underwent an
arteriogram for carotid disease had a noninvasive study. I don’t
consider that redundant. It is preferable to go into an angiogram
procedure knowing what you are looking for and knowing which
details you need to define.
Dr Kenneth McIntyre (Las Vegas, Nev). One of the prob-
lems here is not whether you can do it but whether we should do
it, and you have made those points very eloquently. But one of the
things I noticed is that you had a high degree of third order arterial
cannulation and, as you know, ca-ching, ca-ching, you get reim-
bursed higher for that than second order. My question to you is
what were the indications specifically for third order arterial can-
nulation? Did you really need to do that?
Dr Schneider. One of the reasons why there is a higher
number of catheterizations is because of those patients that we
included that were evaluated for intracranial pathology. These
patients most commonly require a four-vessel study and perhaps
catheterization distal to the carotid bifurcation.
Dr Marc Sedwitz (La Jolla, Calif). I enjoyed your talk im-
mensely. I think it really develops for us the documentation and the
conversations we need to have about what is the appropriate
workup. I would like to know a couple of answers. What do you do
with the renal failure patient? I’d like to know where you look atthe patients with the duplex scans that shows acute occlusion,
where you are worried about possible pseudo-occlusion or the
internal carotid artery, where you put the approach for the acute
thrombosis patient, the patient who comes in with a stroke and
possibly an occlusion in terms of doing angiograms, and your
overall algorithm now for putting the angiogram into duplex,
MRA and CTA.
Dr Schneider. For severe renal insufficiency, we perform
arteriography with gadolinium and dilute iodinated contrast.
There are not a lot of published data on gadolinium. It is on the
anecdotal case report level at this point, but we can limit the
amount of contrast we use. One thing I don’t have available for you
is the number of patients, albeit small, in whom we decided not to
perform arteriography because it was not worth the risk.
Acute carotid thrombosis: I have not personally attempted
recanalizing any of those. However, at Texas Tech they have, and
they might share with us how they approach those patients.
The third one you asked about was where arteriography is in
the algorithm. My own practice has evolved significantly over the
past few years to the point where I am performing pre-treatment
carotid arteriography on the majority of patients. All else being
equal, if the choice is between carotid endarterectomy and carotid
stent, the best deciding factor is carotid arteriography.
Dr William Quinones-Baldrich (Los Angeles, Calif). Dr
Schneider, I congratulate you on some fantastic results. As a
member of the group that sort of early on decided that maybe
arteriography was not necessary and we were sort of criticized
severely for it in the early 80, I struggle with—if it wasn’t necessary
then, why is it necessary now? Well the answer is because we have
carotid angioplasty and stenting. However, just like if you look at
a parallel with carotid endarterectomy, if everybody was able to get
the best results that are reported in the literature, that is, less than
1% risk of stroke in asymptomatic patients with carotid endarter-
ectomy, there would be no trial comparing it to carotid angioplasty
and stenting because it would be obvious that carotid angioplasty
and stenting would not be as good. I have two questions for you.
The first is, if you had done your review and you would have
found that you did indeed have the average stroke risk of a carotid
arteriography, which is 1%, would you still be recommending that
it be done? I suspect that if you look at an average of people doing
carotid angiography that is the risk of stroke, so would you still be
recommending that it be done routinely?
The second question is, since you did both carotid duplex scan
and angiography in all of these patients, could you tell us how
many times did it change your management based on the findings
of the arteriogram compared to the duplex?
Dr Schneider. Those are good questions. I think the risk of
carotid arteriography theoretically should be added to the risk of
carotid stent. You can do most endarterectomies without carotid
arteriography. Because those risks are additive, I think that if the
risk of carotid arteriography is prohibitive, it really calls into
question stenting as an option.
The other important factor, however, is that the risk of carotid
arteriography was unacceptable before. That is why we put all the
effort into making it mostly unnecessary prior to carotid endarter-
ectomy. Now, things have changed. I’ll bet that when other people
look, like we have, they are going to find that the risk of arteriog-
raphy is really quite low. The improving results with carotid
stenting cannot be ignored. Don’t forget that stenting doesn’t
have to be better than endarterectomy. It only has to be in the
ballpark. Even ardent endarterectomists will tell you that there are
some patients who are better treated with a stent. The sooner we
re-familiarize ourselves with carotid arteriography, the more able
we will be to offer all modes of therapy to our patients.
Dr Michael Silva (Lubbock, Tex). This is going to be a
hard-hitting question for you, Dr. Schneider, on what is clearly an
unethical presentation of an unethical practice, all these angio-
grams. I think that you are wringing your hands really much too
much because the question “is carotid angiography necessary to
make an incision and put clamps on the carotid artery and take a
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viewer, when he said are these strategic angiograms, gets at the
heart of the issue.
You can’t separate carotid angioplasty and stenting from ca-
rotid angiography, which you know, having been part of the
discussions, people are still trying to feel around and figure out. I
want you to comment on that for us. Most all of these arterio-
grams, just like most every arteriogram we do, are designed to
provide the treatment for a problem.
The time when we did an arteriogram to get information to
diagnose a problem is over. I would suggest that all of the arte-
riography we do is designed to allow us to appropriately treat the
patient. We go on to do that most of the time with angioplasty and
stenting. But here is the question, as we move, again getting past
the obfuscating arguments of whether you should do carotid artery
angioplasty and stenting, let’s just accept as a hypothesis for the
debate that we are going to do it and we want to do it. In the
credentialing or in this next year or two, do you think that it is
important that we add as part of the box list that needs to be
checked off that people do diagnostic carotid arteriography? Or, is
it possible to say “well, you should just do some angioplasty and
stenting procedures in the carotid” and there shouldn’t be a
number of diagnostic arteriograms apart of that.
Dr Schneider. I don’t think we are going to get to decide that
because a standards document recommending 30 carotid angios
and 25 carotid stents as prerequisite for privileges was published in
JACC with the endorsement of the SVS.
Dr Silva.Right. For the guys in the audience, you are going toa part of the vascular surgery community, even people who stent,
who think that you shouldn’t ask people to come up with a number
of diagnostic carotid catheterizations as part of our targets for what
we should do to be credentialed to do stenting. Their rationale, I
think, is paradoxically it may be difficult in your institution to get
people to say it is okay for you to do carotid angiography but easier
in your institution to get them to say you can do a carotid
angioplasty and stent since nobody is doing that yet. I think the
reality, though, being in a place where a lot of people come and
learn and go back and start this, is that they are inseparable of
course. You can’t do an angioplasty and stenting procedure with-
out doing catheterizations of those arteries, and if you look at the
30 people that we trained, all of them do diagnostic, if you will,
angiography andmaybe two-thirds of them do the stenting. I think
that if you have done some of these procedures, you will more
rapidly be able to do the angioplasty and stenting. I think it is
difficult to separate the two.
Dr Schneider. I agree.
Dr John Connolly (Orange, Calif). I’d like to congratulate
Dr Schneider for bringing this subject to our attention. It was
superbly presented. It might be interesting for me to recollect that
before the Selinger technique of arteriography was discovered,
there was no competition between the vascular surgeon and the
radiologist. They let us do all the angiography, and for the carotids
you may not know that we used to do direct sticks of the carotid
artery, the surgeon did that, and for the arch we did a retrograde
stick through the sternal notch into the arch of the aorta. I don’t
know whether there are any papers to indicate the complicationhave to really start teasing this apart. There is a part of us, there is rate, but it wasn’t as bad as you might think.
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